Mid-Year Report

HEART RHYTHM SOCIETY for HEART RHYTHM SOCIETY

Firm
Client
Income
—
Expenses
$27,804

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Physician Payment

LobbyistCovered position, as disclosed
AMY MELNICK N/A
NEVENA MINOR N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

HR 493 : Genetic Information Non Discrimination Act FDA Appropriation

LobbyistCovered position, as disclosed
AMY MELNICK N/A
NEVENA MINOR N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 493 (110th)

Budget/Appropriations BUD

HR 3043: NIH-CDC-AHRQ Appropriations FDA Appropriations

LobbyistCovered position, as disclosed
AMY MELNICK N/A
NEVENA MINOR N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3043 (110th)

Medical/Disease Research/Clinical Labs MED

S.830: Pediatric Medical Device Safety and Improvement Act

LobbyistCovered position, as disclosed
AMY MELNICK N/A
NEVENA MINOR N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 830 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.